EPO Patents = 13

Forward Citations = 1

Loading Chart...

3 inventors (with patents filed for the assignee):

Dirk Lochmann (9 out of 16 patents)

Sebastian Reyer (9 out of 16 patents)

Michael Stehr (9 out of 15 patents)

9 patents: Sort by Forward Citations

1. 12674026 - Process for preparing polyol-based esters of acyl-capped hydroxy carboxylic acids (2026-07-07),

2. 12577190 - Method for producing polyol-based esters of ketocarboxylic acids (2026-03-17),

3. 12570599 - Process for preparing acyl-capped 3-hydroxycarboxylic acids and their salts and esters (2026-03-10),

4. 12421530 - Method for producing glycerides of hydroxycarboxylic acids (2025-09-23),

5. 12415774 - Polyol-based esters of hydroxycarboxylic acids (2025-09-16),

6. 12365645 - Method for producing fatty alcohol esters of hydroxycarboxylic acids (2025-07-22),

7. 12258609 - Method for producing glycerides of hydroxycarboxylic acids (2025-03-25),

8. 12091383 - Method for producing lipids comprising structural units based on glycerides of hydroxycarboxylc acids (2024-09-17),

9. 11919851 - Method for producing polyol-based esters of optionally acylated hydroxycarboxylic acids (2024-03-05),

Company Overview

Ketolipix Therapeutics GmbH is a biopharmaceutical company focused on developing innovative therapies for metabolic disorders. The company specializes in the research and development of novel lipid-based treatments aimed at addressing conditions such as obesity and diabetes. With a commitment to advancing healthcare through scientific innovation, Ketolipix Therapeutics leverages cutting-edge technology and a team of experienced professionals to bring new solutions to market. Their pipeline includes several promising candidates that are currently in various stages of clinical development, aiming to improve patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#95 in

#4,072 in Germany

DE

Ketolipix Therapeutics Gmbh

Forward Citations = 1

3 inventors:

Dirk Lochmann (9 out of 16 patents)

Sebastian Reyer (9 out of 16 patents)

Michael Stehr (9 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Ketolipix Therapeutics Gmbh. Retrieved from https://idiyas.com/company/ketolipix-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

13 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]